For years, radiation oncologists have been telling patients to avoid applying topical creams, lotions, or emollients immediately before radiation treatment. That instruction was based on a concern ...

- Treatment with ruxolitinib cream (Opzelura™) resulted in facial repigmentation at Week 24, characterized by a significant proportion of patients achieving ≥75% improvement from baseline in the ...

Late-breaking findings at the 2022 American Academy of Dermatology Annual Meeting showed ruxolitinib cream was associated with clinically significant improvement in facial and total body ...

Roflumilast cream 0.05% showed durable efficacy and long-term tolerability in children aged 2 to 5 years with atopic dermatitis over 56 weeks. The cream demonstrated high application-site tolerability ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Clascoterone ...

Please provide your email address to receive an email when new articles are posted on . 37.4% of patients with Fitzpatrick skin types IV to VI and 38.7% of the total ...

- Results will be featured as an oral presentation in a late-breaking abstract session at the 2022 American Academy of Dermatology (AAD) Annual Meeting The 52-week results build on the previously ...